Transplant Co. Hit With Investor Suit Over Bundling Probe
Executives and directors at CareDx Inc. opened the organ transplant services company up to federal probes and liability by improperly bundling expensive testing services with the at-home blood drawing service it launched in response...To view the full article, register now.
Already a subscriber? Click here to view full article